Abstract
To identify overlapping and non‐overlapping functions for TSP‐1 and αvβ6, we crossed TSP‐1‐null and β6‐null mice and compared the phenotype of the double‐null mice with those of wild‐type and single‐null mice. The double‐null mice exhibited focal acute and organizing pneumonia that was more severe than the wild‐type and single‐null mice as well as a significantly higher incidence of inflammation in tissues other than the lung. The TSP‐1‐null and β6‐null mice exhibited a five to eight‐fold increase in granulocyte recruitment to the lung three days after exposure to lipopolysaacharide. They also had abnormalities that were infrequently observed in the wild‐type and single‐null mice, including heart degeneration (8.35% in wild‐type and 28.1% in double‐null mice), hyperplasia of the glandular epithelium of the stomach (2.8% in wild‐type and 21.1% in double‐null mice) and endometrial hyperplasia (0% in wild‐type and 38.5% in double‐null females). Furthermore, the β6‐null and double‐null mice displayed a significant elevation in benign and malignant cancers. Stomach papillomas, squamous cell carcinomas of the ear and stomach, and adenocarcinomas of the lungs, vagina/cervix and colon were observed with the highest frequency. These data demonstrate that TSP‐1 and αvβ6 are involved in regulation of the immune system and epithelial homeostasis. They also indicate that αvβ6 functions as a tumor suppressor gene and that activation of TGFβ by TSP‐1 and αvβ6 contributes to normal tissue architecture and function.
Keywords: Thrombospondin‐1, αvβ6 ‐TGF‐β, inflammation, cancer
References
- 1. Chen H, Herndon ME, Lawler J. The cell biology of thrombospondin‐1. Matrix Biol. 2000; 19: 597–614. [DOI] [PubMed] [Google Scholar]
- 2. Pittet J‐F, Griffiths MJD, Geiser T, Kaminski N, Dalton SL, Huang X, Brown LAS, Gotwals PJ, Koteliansky VE, Matthay MA, Sheppard D. TGF‐β is a critical mediator of acute lung injury. J Clin Invest. 2001; 107: 1537–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Hata A. TGFβ signaling and cancer. Exper Cell Res. 2001; 264: 111–6. [DOI] [PubMed] [Google Scholar]
- 4. Ma L‐J, Yang H, Gaspert A, Carlesso G, Barty MM, Davidson JM, Sheppard D, Fogo A. Transforming growth factor‐β‐dependent and ‐independent pathways of induction of tubulointerstitial fibrosis in β6 ‐/‐ mice. Am J Pathol. 2003; 163: 1261–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Yee KO, Streit M, Hawighorst T, Detmar M, Lawler J. Expression of the type‐1 repeats of thrombospondin‐1 inhibits tumor growth through activation of TGF‐β. Am J Pathol. 2004. [DOI] [PMC free article] [PubMed]
- 6. Lawler J, Sunday M, Thibert V, Duquette M, George EL, Rayburn H, Hynes RO. Thrombospondin‐1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest. 1998; 101: 982–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Crawford SE, Stellmach V, Murphy‐Ullrich JE, Ribeiro SMF, Lawler J, Hynes RO, Boivin GP, Bouck N. Thrombospondin‐1 is a major activator of TGF‐β1 in vivo. Cell 1998; 93: 1159–70. [DOI] [PubMed] [Google Scholar]
- 8. Schultz‐Cherry S, Lawler J, Murphy‐Ullrich JE. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor β. J Biol Chem. 1994; 269: 26783–8. [PubMed] [Google Scholar]
- 9. Schultz‐Cherry S, Ribeiro S, Gentry L, Murphy‐ Ullrich JE. Thrombospondin binds and activates the small and large forms of latent transforming growth factor‐β in a chemically defined system. J Biol Chem. 1994; 269: 26775–82. [PubMed] [Google Scholar]
- 10. Schultz‐Cherry S, Chen H, Mosher DF, Misenheimer TM, Krutzsch HC, Roberts DD, Murphy‐Ullrich JE. Regulation of transforming growth factor‐β activation by discrete sequences of thrombospondin‐1. J Biol Chem. 1995; 270: 7304–10. [DOI] [PubMed] [Google Scholar]
- 11. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annuziata N, Doetschman T. Targeted disruption of the mouse transforming growth factor‐β1 gene results in multifocal inflammatory disease. Nature 1992; 359: 693–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Breuss JM, Gallo J, DeLisser HM, Klimanskaya IV, Folkesson HG, Pittet JF, Nishimura SL, Aldape K, Landers DV, Carpenter W, Gillett N, Sheppard D, Matthay MA, Albelda SM, Kramer RH, Pytela R. Expression of the β6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci. 1988; 108: 2241–51. [DOI] [PubMed] [Google Scholar]
- 13. Huang X‐Z, Wu JF, Cass D, Erle DJ, Corry D, Young SG, Farese RV Jr., Sheppard D. Inactivation of the integrin b6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lungs and skin. J Cell Biol. 1996; 133: 921–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Gu X, Niu J, Dorahy DJ, Scott RJ, Agrez MV. Integrin αvβ6‐associated ERK2 mediates MMP‐9 secretion in colon cancer cells. Br J Cancer 2002; 87: 348–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Thomas GJ, Lewis MP, Hart IR, Marshall JF, Speight PM. αvβ6 integrin promotes invasion of squamous carcinoma cells through up‐regularion of matrix metalloproteinase‐9. Int J Cancer 2001; 92: 641–50. [DOI] [PubMed] [Google Scholar]
- 16. Arihiro K, Kaneko M, Fujii S, Inai K, Yokosaki Y. Significance of α9β1 and αvβ6 integrin expression in breast carcinoma. Breast Cancer 2000; 7: 19–26. [DOI] [PubMed] [Google Scholar]
- 17. Munger JS, Huang X, Kawakatsu H, Griffiths MJD, Dalton SL, Wu J, Pittet J‐F, Kaminski N, Garat C, Matthay MA, Rifkin DB, Sheppard D. The integrin αvβ6 binds and activates latent TGFβ‐1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999; 96: 319–28. [DOI] [PubMed] [Google Scholar]
- 18. Laird PW, Zijderveld A, Linders K, Rudnicki MA, Jaenisch R, Berns A. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 1991; 19: 4293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Chignard M, Balloy V. Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccaride. Am J Physiol Lung Cell Mol Physiol. 2000; 279: L1083–90. [DOI] [PubMed] [Google Scholar]
- 20. Huang X‐Z, Wu JF, Zhu W, Pytela R, Sheppard D. Expression of the human integrin β6 subunit in alveolar type II cells and bronchioloar epithelial cells reverses lung inflammation in β6 knockout mice. Am J Respir Cell Mol Biol. 1998; 19: 636–42. [DOI] [PubMed] [Google Scholar]
- 21. Epler GR. Bronchiolitis obliterans organizing pneumonia. Arch Intern Med. 2001; 161: 158–63. [DOI] [PubMed] [Google Scholar]
- 22. Boivin GP, O'Toole BA, Orsmby IE, Diebold RJ, Eis MJ, Doetschman T, Kier AB. Onset and progression of pathological lesions in transforming gowth factor‐β1‐deficient mice. Am J Pathol. 1995; 146: 276–88. [PMC free article] [PubMed] [Google Scholar]
- 23. Iruela‐Arispe ML, Porter P, Bornstein P, Sage EH. Thrombospondin‐1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J Clin Invest. 1996; 97: 403–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Rogers P, Abberton K, Susil B. Endothelial cell migratory signal produced by human endometrium during the menstrual cycle. Hum Reprod. 1992; 7: 1061–6. [DOI] [PubMed] [Google Scholar]
- 25. Corless C, Mendoza A, Collins T, Lawler J. Colocalization of thrombospondin‐1 and syndecan during murine development. Dev Dyn. 1992; 193: 346–58. [DOI] [PubMed] [Google Scholar]
- 26. Sipos B, Hahn D, Carceller A, Piulats J, Hedderich J, Kalthoff H, Goodman S, Kosmahl M, Klöppel G. Immunohistochemical screening for β6‐integrin subunit expression in adnocarcinomas using a novel monoclonal antibody reveals strong up‐regulation in pancreatic ductal adenocarcinomas in vivo and in vitro. Histopathology 2004; 45: 226–36. [DOI] [PubMed] [Google Scholar]
- 27. Basson MD, Modlin IM, Flynn S, Jena B, Madri J. Independent modulation of enterocyte migration and proliferation by growth factors, matrix proteins, and pharmacologic agents in an in vitro model of mucosal healing. Surgery 1992; 112: 299–307. [PubMed] [Google Scholar]
- 28. Ciacci G, Lind S, Podolsky D. Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolayers. Gastroenterology 1993; 105: 93–101. [DOI] [PubMed] [Google Scholar]
- 29. Szabo S, Kusstatscher S, Sandor Z, Asakoulas G. Molecular and cellular basis of ulcer healing. Scand J. Gastroenterol. [Suppl.] 1995; 208: 3–8. [DOI] [PubMed] [Google Scholar]
- 30. Naef M, Ishiwata T, Friess H, Büchler MW, Gold LI, Korc M. Differential localization of transforming growth factor‐β isoforms in human gastric mucosa and overexpression in gastric carcinoma. Int J Cancer. 1997; 71: 131β7. [DOI] [PubMed] [Google Scholar]
- 31. Basque J‐R, Chailler P, Ménard D. Laminins and TGF‐ β maintain cell polarity and functionality of human gastric glandular epithelium. Am J Physiol Cell Physiol. 2002; 282: C873–84. [DOI] [PubMed] [Google Scholar]
- 32. Yoshiura K, Ota S, Terano A, Takahashi M, Hata Y, Kawabe T, Mutoh H, Hiraishi H, Nakata R, Okano K. Growth regulation of rabbit gastric epithelial cells and protoonocogene expression. Digest Disease Sci. 1994; 39: 1454–63. [DOI] [PubMed] [Google Scholar]
- 33. Knight PA, Wright SH, Brown JK, Huang X, Sheppard D, Miller HRP. Enteric expression of the integrin αvβ6 is essential for nematode‐induced mucosal mast cell hyperplasia and expression of the granule chymase, mouse mast cell protease‐1. Am J Pathol. 2002; 161: 771–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Boivin GP, Molina JR, Ormsby I, Stemmermann G, Doetschman T. Gastric lesions in transforming growth factorβ‐1 heterzygous mice. Lab Invest. 1996; 74: 513–8. [PubMed] [Google Scholar]
- 35. Li X, Yang Y, Hu Y, Dang D, Regezi J, Schmidt BL, Atakilit A, Chen B, Ellis D, Ramos DM. αvβ6‐Fyn signaling promotes oral cancer progression. J Biol Chem. 2003; 278: 41646–53. [DOI] [PubMed] [Google Scholar]
- 36. Thomas GJ, Lewis MP, Whawell SA, Russell A, Sheppard D, Hart IR, Speight PM, Marshall JF. Expression of the αvβ6 integrin promotes migration and invasion in squamous carcinoma cells. J Invest Dermatol. 2001; 117: 67–73. [DOI] [PubMed] [Google Scholar]
- 37. Gutierrez LS, Suckow M, Lawler J, Ploplis VA, Castellino FJ. Thrombospondin 1‐a regulator of adenoma growth and carcinoma progression in the APCMin/+ mouse model. Carcinogenesis 2003; 24: 199–207. [DOI] [PubMed] [Google Scholar]